BACKGROUND: Adenocarcinomas of the pancreas are characterized by a rapid progression, an early metastasis, a limited response to chemo- and radiotherapy, and an intense fibrotic reaction known as tumor desmoplasia. Carcinoma cells are surrounded by a dense stroma consisting of myofibroblast-like cells, collagens, and fibronectin. MATERIALS AND METHODS: This review describes the interaction of activated pancreatic stellate cells (myofibroblast-like cells) with tumor cells in pancreas adenocarcinomas. Our data were obtained in cell culture experiments and in in vivo investigations. RESULTS: Carcinoma cells produce soluble mediators and stimulate motility, proliferation, matrix-, and MMP synthesis of stellate cells. Vice versa-activated stellate cells release mitogens, stimulating proliferation of cancer cells. Cancer cell proliferation and resistance to apoptosis might further be induced by the microenvironment (extracellular matrix), which is primarily provided by stellate cells. A very important aspect in the interaction of stellate cells with cancer cells is the expression of EMMPRIN (extracellular matrix metalloproteinase inducer) by cancer cells, the shedding of the extracellular part of EMMPRIN by matrix metalloproteinases (MMPs), and the induction of MMPs in stellate cells by soluble EMMPRIN. In particular, the stellate cells in close proximity to tumor cells therefore express MMPs and degrade connective tissue. CONCLUSION: Through complex interactions between stellate cells and carcinoma cells, tumor progression and cancer cell invasion are accelerated. As we gain better understanding of these mechanisms, adequate therapies to reduce tumor cell invasion and cancer progression might be developed.
BACKGROUND:Adenocarcinomas of the pancreas are characterized by a rapid progression, an early metastasis, a limited response to chemo- and radiotherapy, and an intense fibrotic reaction known as tumor desmoplasia. Carcinoma cells are surrounded by a dense stroma consisting of myofibroblast-like cells, collagens, and fibronectin. MATERIALS AND METHODS: This review describes the interaction of activated pancreatic stellate cells (myofibroblast-like cells) with tumor cells in pancreas adenocarcinomas. Our data were obtained in cell culture experiments and in in vivo investigations. RESULTS:Carcinoma cells produce soluble mediators and stimulate motility, proliferation, matrix-, and MMP synthesis of stellate cells. Vice versa-activated stellate cells release mitogens, stimulating proliferation of cancer cells. Cancer cell proliferation and resistance to apoptosis might further be induced by the microenvironment (extracellular matrix), which is primarily provided by stellate cells. A very important aspect in the interaction of stellate cells with cancer cells is the expression of EMMPRIN (extracellular matrix metalloproteinase inducer) by cancer cells, the shedding of the extracellular part of EMMPRIN by matrix metalloproteinases (MMPs), and the induction of MMPs in stellate cells by soluble EMMPRIN. In particular, the stellate cells in close proximity to tumor cells therefore express MMPs and degrade connective tissue. CONCLUSION: Through complex interactions between stellate cells and carcinoma cells, tumor progression and cancer cell invasion are accelerated. As we gain better understanding of these mechanisms, adequate therapies to reduce tumor cell invasion and cancer progression might be developed.
Authors: S Zucker; M Hymowitz; E E Rollo; R Mann; C E Conner; J Cao; H D Foda; D C Tompkins; B P Toole Journal: Am J Pathol Date: 2001-06 Impact factor: 4.307
Authors: Max G Bachem; Marion Schünemann; Marco Ramadani; Marco Siech; Hans Beger; Andreas Buck; Shaoxia Zhou; Alexandra Schmid-Kotsas; Guido Adler Journal: Gastroenterology Date: 2005-04 Impact factor: 22.682
Authors: Malte Buchholz; Hans A Kestler; Karlheinz Holzmann; Volker Ellenrieder; Wilhelm Schneiderhan; Marco Siech; Guido Adler; Max G Bachem; Thomas M Gress Journal: J Mol Med (Berl) Date: 2005-06-23 Impact factor: 4.599
Authors: T Imamura; H Iguchi; T Manabe; G Ohshio; T Yoshimura; Z H Wang; H Suwa; S Ishigami; M Imamura Journal: Pancreas Date: 1995-11 Impact factor: 3.327
Authors: M V Apte; P S Haber; T L Applegate; I D Norton; G W McCaughan; M A Korsten; R C Pirola; J S Wilson Journal: Gut Date: 1998-07 Impact factor: 23.059
Authors: M G Bachem; E Schneider; H Gross; H Weidenbach; R M Schmid; A Menke; M Siech; H Beger; A Grünert; G Adler Journal: Gastroenterology Date: 1998-08 Impact factor: 22.682
Authors: Erica A Marieb; Alexandra Zoltan-Jones; Rongsong Li; Suniti Misra; Shibnath Ghatak; Jian Cao; Stanley Zucker; Bryan P Toole Journal: Cancer Res Date: 2004-02-15 Impact factor: 12.701
Authors: Stacey J Coleman; Jennifer Watt; Prabhu Arumugam; Leonardo Solaini; Elisabeta Carapuca; Mohammed Ghallab; Richard P Grose; Hemant M Kocher Journal: World J Gastroenterol Date: 2014-07-14 Impact factor: 5.742
Authors: Famke Aeffner; Nathan T Martin; Mirza Peljto; Joshua C Black; Justin K Major; Maryam Jangani; Michael O Ports; Joseph S Krueger; G David Young Journal: Lab Invest Date: 2016-10-24 Impact factor: 5.662
Authors: Song Han; Daniel Delitto; Dongyu Zhang; Heather L Sorenson; George A Sarosi; Ryan M Thomas; Kevin E Behrns; Shannon M Wallet; Jose G Trevino; Steven J Hughes Journal: Lab Invest Date: 2015-08-31 Impact factor: 5.662
Authors: Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam Journal: PLoS One Date: 2010-02-11 Impact factor: 3.240